Molecular biology of advanced NSCLC and survival: seeking the best therapy
Conclusions: In our hospital, molecular diagnostic is performed in all patients with advanced NSCLC to customize therapy. This study, while showing our local experience, corroborates data obtained in the literature. Thus, despite the small sample size, this may be the basis for future studies and help improve clinical practice.
Source: European Respiratory Journal - Category: Respiratory Medicine Authors: Martins Baptista, M., Martins, N., Barata, J., Silva, R., Martins, S., Craveiro, A., Valente, M. J., Magalhaes, E., Vicente, I., Valente, M. L. S. Tags: Lung cancer Source Type: research
More News: Biology | Cancer | Cancer & Oncology | Chemotherapy | Immunotherapy | Lung Cancer | Molecular Biology | Non-Small Cell Lung Cancer | Portugal Health | Respiratory Medicine | Smokers | Study | Weight Loss